文献速递心外重症与机械循环支持

连续流左心室辅助装置植入同期三尖瓣手术的长期结局

Long-term outcomes of tricuspid valve repair or replacement in patients with a continuous-flow left ventricular assist device.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-09-05

该回顾性研究纳入2004至2023年接受HeartMate II或3 LVAD植入的727例患者,经倾向性评分匹配比较同期三尖瓣手术(TVP)与单纯LVAD的长期结局。匹配后每组90例,TVP组术后1年死亡率与对照组相当,但1年后死亡风险更低,且三尖瓣反流程度更轻,再住院风险相似。

要点

  • 同期TVP与LVAD植入不增加术后1年死亡风险。
  • 术后1年后TVP组死亡风险显著低于单纯LVAD组。
  • TVP组长期三尖瓣反流程度更轻,再住院风险相似。

核心结论

  • 同期TVP与LVAD植入在8年随访中与降低死亡率和减轻三尖瓣反流程度相关。
  • 两组再住院风险相似。

研究设计与样本

  • 回顾性队列研究,纳入2004至2023年接受HeartMate II或3 LVAD植入的患者。
  • 排除9例既往有TVP的患者,最终分析727例,其中TVP组102例(76例修复,26例置换),无TVP组625例。
  • 采用倾向性评分匹配(PSM)形成每组90例的匹配队列。

主要发现

  • 匹配队列中位年龄59.0岁(IQR 49.2-67.0岁),男性144例(80.0%),172例(95.6%)为destination therapy,61例(33.9%)为缺血性心肌病。

临床怎么用

  • 对于接受连续流LVAD植入且合并三尖瓣反流的患者,可考虑同期行三尖瓣手术以改善长期生存和三尖瓣反流。
  • 同期TVP不增加术后1年死亡风险,但需注意远期获益。

局限性

  • 回顾性研究设计。
  • 样本来自单中心,可能存在选择偏倚。
  • 匹配后样本量较小(每组90例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the long-term outcomes of concomitant tricuspid valve procedures (TVP) during continuous-flow left ventricular assist device (LVAD) implantation. METHODS: We retrospectively reviewed patients who received a HeartMate II or 3 LVAD between 2004 and 2023. Nine patients who had a previous TVP were excluded. Patients with a concurrent TVP were compared to those who received an LVAD alone using propensity score matching (PSM). The primary outcomes were survival, number of rehospitalizations, and long-term tricuspid regurgitation (TR). RESULTS: The study cohort comprised 727 patients, including 102 (14.0%) with a concomitant TVP (TVP group: 76 repairs, 26 replacements) and 625 (86.0%) without a TVP (No TVP group). PSM created 2 cohorts of 90 patients each. The median age of the matched cohorts was 59.0 years (interquartile range, 49.2-67.0 years). There were 144 males (80.0%), 172 patients (95.6%) who received LVAD as destination therapy, and 61 patients (33.9%) with ischemic cardiomyopathy. Within the first year after surgery, mortality was comparable in the 2 groups (adjusted hazard ratio [HR], 1.36; 95% confidence interval [CI], 0.63-2.90; P = .29). After the first year, the TVP group had a lower risk of mortality compared to the No TVP group (HR, 0.227; 95% CI, 0.082-0.633; P < .01). The 2 groups had a comparable risk of readmission (HR, 1.115; 95% CI, 0.777-1.601; P = .55). The TVP group had lower degrees of TR over time (P < .001). CONCLUSIONS: Concomitant TVP with LVAD implantation was associated with reduced mortality and reduced grade of TR over an 8-year follow-up period, while readmissions were similar in comparable patients without TVP.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Shah S, Wang C, Camacho GA, et al. Long-term outcomes of tricuspid valve repair or replacement in patients with a continuous-flow left ventricular assist device. J Thorac Cardiovasc Surg. 2025. PMID: 40915411. doi:10.1016/j.jtcvs.2025.08.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。